New York Approves Mandatory Acupuncture Coverage by Health Insurance Plans

The New York State Legislative Assembly has approved bill A.622, which mandates the inclusion of acupuncture in the coverage of large group health insurance plans. The measure represents a significant regulatory advance for medical acupuncture in the United States, signaling institutional recognition of the modality as a legitimate therapeutic resource in addressing chronic conditions, particularly persistent pain.

Context: Acupuncture and the Opioid Crisis

The bill comes in a scenario in which US public-health authorities seek non-pharmacologic alternatives for chronic-pain management, in face of the devastating effects of the opioid crisis. The bill’s authors argue that medical acupuncture offers a safe and evidence-based approach to painful conditions, reducing dependence on analgesics with abuse potential. The scientific literature accumulated in recent decades demonstrates the efficacy of acupuncture in various chronic pain syndromes, including low back pain, tension-type headache, and osteoarthritis.

Treatment Access Barrier

Despite the robust body of clinical evidence, the absence of mandatory coverage remains a central obstacle to access to medical acupuncture in much of the United States. Without reimbursement by health plans, treatment becomes viable only for patients with the ability to bear the costs directly, perpetuating an inequality in access to evidence-based care. The approval of A.622 seeks to correct this gap in the state of New York, potentially serving as a regulatory model for other states.

Next Steps

Bill A.622 now proceeds to the New York State Senate. If approved at that stage, it will be sent to the governor for signature. The process occurs at a moment of growing legislative recognition of acupuncture in the United States, with several states advancing similar coverage-expansion initiatives. For the medical community that practices acupuncture, regulatory decisions like this consolidate the place of the modality within evidence-based medicine and broaden patient access to safe and effective complementary treatments.